Phase 4 Colorectal Cancer Trial, Recruiting NCT06935708 Sponsor: Meri Mirceta Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 4 Colorectal Cancer Trial, Recruiting

NCT06935708
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years who have colorectal cancer and are having laparoscopic (keyhole) abdominal surgery
  • People rated as ASA Class I, II, or III (a standard measure used by anaesthetists to describe overall health before surgery) (confirm with trial site)
  • People with a Body Mass Index (BMI) between 15 and 35

Who may not be able to join:

  • People with abnormal blood clotting, including those whose clotting test results are outside normal ranges or whose INR score is 1.4 or higher, or who are currently taking blood-thinning medication
  • People with a low platelet count (a blood cell type needed for clotting), measured below a certain threshold
  • People with a skin infection at the area of the back where the anaesthetic needle would be inserted
  • People with an existing nerve condition, including nerve damage in the hands or feet
  • People with dementia or any other condition that makes communication difficult
  • People with a slow heart rate (fewer than 50 beats per minute) or with a heart rhythm conduction problem of the second or third degree
  • People with a history of opioid (strong painkiller) misuse or dependency
  • People with known allergies to any of the medications used in the study
  • People whose keyhole surgery is converted to open surgery during the procedure
  • People who experience complications after surgery that require a return to the operating theatre
  • People for whom placement of the spinal or epidural anaesthetic is unsuccessful, even after an attempt by a senior anaesthetist

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +38521556180

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Meri Mirceta
Registry
ClinicalTrials.gov
Start date
8 April 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇭🇷 Croatia

Primary endpoints

Pain intensity at rest 24 hours after surgery.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov